Jennison Associates LLC Argenx Se Transaction History
Jennison Associates LLC
- $162 Billion
- Q4 2024
A detailed history of Jennison Associates LLC transactions in Argenx Se stock. As of the latest transaction made, Jennison Associates LLC holds 302,149 shares of ARGX stock, worth $192 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
302,149
Previous 237,966
26.97%
Holding current value
$192 Million
Previous $129 Million
43.98%
% of portfolio
0.11%
Previous 0.08%
Shares
30 transactions
Others Institutions Holding ARGX
# of Institutions
433Shares Held
29.2MCall Options Held
390KPut Options Held
272K-
Price T Rowe Associates Inc Baltimore, MD5.52MShares$3.51 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.07MShares$1.95 Billion3.02% of portfolio
-
Janus Henderson Group PLC London, X02.31MShares$1.47 Billion0.76% of portfolio
-
Capital World Investors Los Angeles, CA1.79MShares$1.14 Billion0.17% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$788 Million11.1% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $35.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...